Optimi Health to become a global leader in all-natural psilocybin production VANCOUVER, British Columbia, Feb. 07, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom brand targeting functional and novel psychedelic compounds for the health and wellness sector, is pleased to report that Optimi…


Previous articlePsychedelic Research Bulletin: January 2022
Next articlePT291 – Rick Tarnas & Sean Kelly, Ph.D. – The Impact of Stanislav Grof, Ego Death, and The Psyche Unbound